umifenovir has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bernreuther, C; de Lamballerie, X; Emmerich, P; Günther, S; Krasemann, S; Lehmann, M; Neumann, M; Oestereich, L; Ölschläger, S; Rieger, T; Wurr, S | 1 |
| Falynskova, IN; Fedyakina, IT; Leneva, IA; Leonova, EI; Lepekha, LN; Makhmudova, NR; Mikhailova, NA; Osipova, EA; Zverev, VV | 1 |
| Cui, J; Fan, Q; Huang, D; Li, H; Liang, C; Zhang, S; Zhi, C | 1 |
| Brooks, MJ; Burtseva, EI; Crowe, SM; Ellery, PJ; Lew, AM; Marsh, GA; Slepushkin, AN; Tannock, GA | 1 |
| Bondareva, TA; Borisevich, SV; Chernikova, NK; Dorokhina, TV; Khmelev, AL; Shagarova, NV | 1 |
6 other study(ies) available for umifenovir and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Female; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Indoles; Liver; Male; Mice; Mice, Transgenic; Pyrazines; Receptor, Interferon alpha-beta; Ribavirin; Vero Cells | 2014 |
[Umifenovir (Arbidol) efficacy in experimental mixed viral and bacterial pneumonia of mice].
Topics: Administration, Oral; Animals; Antiviral Agents; Bacterial Load; Body Weight; Coinfection; Disease Models, Animal; Drug Administration Schedule; Female; Indoles; Influenza A Virus, H1N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Viral Load | 2014 |
Umifenovir effectively inhibits IL-10 dependent persistent Coxsackie B4 virus infection.
Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; HeLa Cells; Humans; Immunomodulation; Indoles; Interleukin-10; Intracellular Signaling Peptides and Proteins; Mice; Myocarditis; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Spleen | 2017 |
Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions.
Topics: Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Humans; Indoles; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Orthomyxoviridae Infections; Respiratory Tract Infections; Viral Load; Viral Plaque Assay; Viruses | 2012 |
[Estimation of possible use of interferon inductors for prevention of postvaccional reactions to TEOVac in animal models].
Topics: Administration, Intranasal; Administration, Oral; Animals; Disease Models, Animal; Drug Administration Schedule; Guinea Pigs; Humans; Indoles; Interferon Inducers; RNA, Double-Stranded; RNA, Fungal; Smallpox Vaccine; Vaccination; Vaccinia virus | 2011 |